Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment.
Hirt CK, Booij TH, Grob L, Simmler P, Toussaint NC, Keller D, Taube D, Ludwig V, Goryachkin A, Pauli C, Lenggenhager D, Stekhoven DJ, Stirnimann CU, Endhardt K, Ringnalda F, Villiger L, Siebenhüner A, Karkampouna S, De Menna M, Beshay J, Klett H, Kruithof-de Julio M, Schüler J, Schwank G.
Hirt CK, et al. Among authors: ringnalda f.
Cell Genom. 2022 Feb;2(2):100095. doi: 10.1016/j.xgen.2022.100095.
Cell Genom. 2022.
PMID: 35187519
Free PMC article.